Cargando…

Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19

Current standard treatment of COVID-19 lacks in effective antiviral options. Plitidepsin, a cyclic depsipeptide authorized in Australia for patients with refractory multiple myeloma, has recently emerged as a candidate anti-SARS-CoV-2 agent. The aim of this review was to summarize current knowledge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papapanou, Michail, Papoutsi, Eleni, Giannakas, Timoleon, Katsaounou, Paraskevi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306251/ https://www.ncbi.nlm.nih.gov/pubmed/34357135 http://dx.doi.org/10.3390/jpm11070668

Ejemplares similares

Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis
por: Pappa, Sofia, et al.
Publicado: (2020)

Corrigendum to “Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis” [Brain Behav. Immun. 88 (2020) 901–907]
por: Pappa, Sofia, et al.
Publicado: (2021)

Plitidepsin for multiple myeloma
Publicado: (2019)

Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis
por: Sachse, Martin, et al.
Publicado: (2022)

Author reply – Letter to the editor “The challenges of quantifying the psychological burden of COVID-19 on heathcare workers”
por: Pappa, Sofia, et al.
Publicado: (2021)

Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis
por: Soto-Matos, Arturo, et al.
Publicado: (2011)

Global burden of COVID-19 pandemic on healthcare workers
por: Papoutsi, Eleni, et al.
Publicado: (2020)

Effect of COVID-19-Related Lockdown οn Hospital Admissions for Asthma and COPD Exacerbations: Associations with Air Pollution and Patient Characteristics
por: Sigala, Ioanna, et al.
Publicado: (2021)

Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
por: Martinez, Miguel Angel
Publicado: (2021)

Plitidepsin: design, development, and potential place in therapy
por: Alonso-Álvarez, Sara, et al.
Publicado: (2017)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
por: Galmarini, Carlos M., et al.
Publicado: (2014)

Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
por: Varona, Jose F, et al.
Publicado: (2022)

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts
por: Delgado-Calle, Jesus, et al.
Publicado: (2019)

c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity
por: Muñoz-Alonso, María J., et al.
Publicado: (2013)

Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma
por: Plummer, R, et al.
Publicado: (2013)

Lectins and lectibodies: potential promising antiviral agents
por: Nabi-Afjadi, Mohsen, et al.
Publicado: (2022)

Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19
por: Pindiprolu, Sai Kiran S.S., et al.
Publicado: (2020)

Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
por: Mateos, María Victoria, et al.
Publicado: (2022)

Antiviral Effects and Underlying Mechanisms of Probiotics as Promising Antivirals
por: Wang, Yanjin, et al.
Publicado: (2022)

Molecular Mechanisms of Antiviral Agents against Dengue Virus
por: Lee, Michelle Felicia, et al.
Publicado: (2023)

Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
por: Varona, Jose F., et al.
Publicado: (2023)

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
por: White, Kris M., et al.
Publicado: (2021)

Nitrogen-Based Heterocyclic Compounds: A Promising Class of Antiviral Agents against Chikungunya Virus
por: Santana, Andreza C., et al.
Publicado: (2020)

Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy
por: Guisado-Vasco, P., et al.
Publicado: (2021)

Current and Promising Antivirals Against Chikungunya Virus
por: Hucke, Friederike I. L., et al.
Publicado: (2020)

Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review
por: Khazeei Tabari, Mohammad Amin, et al.
Publicado: (2021)

Hydroxy-xanthones as promising antiviral agents: Synthesis and biological evaluation against human coronavirus OC43
por: Dean, Bethanie, et al.
Publicado: (2023)

Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives
por: Taverniti, Valerio, et al.
Publicado: (2022)

Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
por: Dumez, Herlinde, et al.
Publicado: (2009)

Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection
por: Biolatti, Matteo, et al.
Publicado: (2020)

Analysis of acceptance of the smoking ban in Greece
por: Zervas, Efthimios, et al.
Publicado: (2014)

Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2021)

Antiviral Agents Against Respiratory Viruses
por: Ison, Michael G., et al.
Publicado: (2017)

Antiviral agents against respiratory viruses
por: Tremblay, Cecile L.
Publicado: (2001)

Sleep Dysfunction in COVID-19 Patients: Prevalence, Risk Factors, Mechanisms, and Management
por: Pataka, Athanasia, et al.
Publicado: (2021)

Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial
por: Pardanani, A, et al.
Publicado: (2015)

Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
por: Sharma, Divya, et al.
Publicado: (2022)

Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma
por: Schöffski, Patrick, et al.
Publicado: (2009)

Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin
por: Losada, Alejandro, et al.
Publicado: (2016)

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma
por: Spicka, Ivan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8gms6r30mjn2o8nal0rf09ac65